Background: Several imaging techniques may reveal calcifi cation of the arterial wall or cardiac valves. Many studies indicate that the risk for cardiovascular disease is increased when calcifi cation is present. Recent meta-analyses on coronary calcifi cation and cardiovascular risk may be confounded by indication. Therefore, this meta-analysis was performed with extensive subgroup analysis to assess the overall cardiovascular risk of fi nding calcifi cation in any arterial wall or cardiac valve when using different imaging techniques.
Introduction
Several imaging techniques may reveal vascular calcium deposits. Since these deposits are not always the prime reason for the investigation, the presence of calcifi ed blood vessel walls or heart valves is often not recognized as a clinically important sign of vascular risk. Although calcifi cations may occur in small amounts in the earlier stages of atherosclerosis, they are usually seen in more advanced lesions. 1 Indeed, various studies have observed an increased cardiovascular risk in patients with calcifi cation. [2] [3] [4] [5] [6] [7] [8] However, the latter is not a uniform fi nding. 9 This discrepancy may be due to differences in methodology, patient selection and baseline risk. Recent meta-analyses of the relationship between calcifi cation and vascular risk have focused exclusively on coronary calcium scores. 10 As patients with coronary insuffi ciency are more likely to be subjected to diagnostic imaging than others, part of the relationship between coronary calcifi cation and outcome may be confounded by indication. To overcome this problem, we performed the present meta-analysis in which we assessed the impact of calcium deposits in any artery or heart valve, with different imaging techniques, on fatal and nonfatal cardiovascular events as well as total mortality in populations with different baseline risks.
Methods
To identify studies on vascular calcifi cation (mineralization detected in any part of the blood vessel wall or heart valves) and cardiovascular risk, a PubMed, Embase, and
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Cochrane library search was performed using the following search terms: "plain radiography or chest X-ray or abdominal X-ray or mammography or panoramic radiography or ultrasound (US) or computer tomography (CT) or magnetic resonance imaging (MRI)" and (cardiovascular risk or calcifi cation). Two investigators (RJMW Rennenberg and AA Kroon) screened all abstracts and, after applying the criteria for eligibility, decided on whether or not the full papers should be retrieved. All authors reviewed qualifying papers.
Study eligibility
Only prospective cohort studies were eligible. Paediatric studies were excluded. Articles published between 1970 and June 2008, with prospective data on human vascular calcification and well-documented end-points were selected. Case reports were excluded. Data on events in both groups, with and without calcifi cation, had to be reported separately. To be selected for the analysis absolute numbers, ie, a two-by-two table, should be extractable from the text. References found in the selected papers that fulfi lled these criteria were also selected. Only papers published in English, German, Dutch, and French were considered. When data were published in consecutive articles by the same authors only the article with the most comprehensive dataset was considered. 8, [11] [12] [13] Defi nition of end-points End-points were defi ned as all cause mortality, cardiovascular mortality (death from any cardiovascular cause), coronary event (myocardial infarction, coronary mortality, percutaneous coronary angioplasty or coronary artery bypass operation), stroke (ischemic and hemorrhagic) and any cardiovascular event (cardiovascular mortality, coronary event, stroke, peripheral revascularisation procedures or amputation, carotid endarterectomy).
Statistical analysis
Studies reporting data suitable to make two by two tables of calcifi cation in relation to events were used to compute odds ratio's using a random effects meta-analysis. Because we expected signifi cant heterogeneity, a meta-regression analysis with a random effect model was performed, as suggested by Egger and colleagues, 14 taking into account the following variables: duration of follow up, type of imaging technique (plain radiograph, CT, or US) and baseline risk of the population, estimated as low (asymptomatic without known cardiovascular risk factors), intermediate (asymptomatic with one or more cardiovascular risk factors or diabetes but no renal insuffi ciency) and high (symptomatic or renal insuffi ciency). Publication bias was assessed with a funnel plot of the risk for any cardiovascular event. Statistical calculations were done using the STATA statistical program version 8.2 (StataCorp, College Station, TX), with the latest updates.
Results
We originally retrieved over 2,500 articles. Screening of abstracts and exclusion of case-reports resulted in 91 remaining original studies on the association between human vascular or valvular calcifi cations and cardiovascular risk. After applying the eligibility criteria 61 studies were excluded mainly because they were not prospective follow up studies. Only a few studies were excluded because absolute numbers could not be extracted or results were not reported as calcifi cation versus no calcifi cation. The remaining 30 studies, which are summarized in Table 1 , could be included. 3, [5] [6] [7] [8] [9] 13, Ten studies concerned plain radiography, such as mammograms, chest X-rays or X-rays of the peripheral blood vessels (eg, the femoral artery); ten studies had applied CT, mostly of the coronaries, and in 10 studies US had been used, predominantly of the heart valves. On plain radiographs vascular calcifi cations were defi ned as linear densities in the blood vessel area. With CT vascular calcifi cation was defi ned as any vessel part with a density of 130 Hounsfi eld units or more. In the US studies highly echogenic plaques producing bright white echoes with shadowing were noted as calcifi cations. No reports with respect to MRI fulfi lled the inclusion criteria. In these 30 papers, the absolute numbers of events in relation to the presence or absence of calcifi cations were reported, comprising a total of 218,080 subjects. Overall, 53% of the subjects were males. The prevalence of vascular calcifi cations varied according to the patient group studied. The lowest prevalence of 2.3% was found in an asymptomatic population with a mean age of 47 years in which aortic arch calcifi cations on plain chest X-rays were studied. 5 The highest prevalence of 88.9% was found in patients (mean age 56 years) with chest pain in whom coronary calcifi cations were measured by electron beam computer tomography (EBCT). 24 The median prevalence of calcifi cation in all studies was 57.5%. The mean follow up to record the number of cardiovascular events in these studies was 10.1 years (range 2-26).
All cause mortality
In nine studies, with a total of 3,821 deaths among the 40,747 participants, data on all cause mortality were re ported. 11, 17, 19, 22, 27, 28, 33, 36, 37 Odds ratios are depicted in Figure 1 . Among 16,528 subjects with calcifi cations 1,589 deaths were observed. Four of the studies comprised a population with renal insuffi ciency in which the event rate for all cause mortality in patients with calcifi cations was more than 5 times higher than in patients without calcifi cations. Overall OR for mortality from all causes was 4.62 (95% CI 2.24 to 9.53, Figure 1 ). The odds ratio for all cause mortality in patients without renal insuffi ciency was 3.43 (95% CI 1.26 to 9.32).
Cardiovascular mortality
Odds ratios for cardiovascular mortality are also shown in Figure 1 . A total of 1,356 cardiovascular deaths were observed among the 17,187 participants in the 9 studies that reported data on this complication. 8, 9, 13, 22, 27, 28, 30, 33, 36 Among 3,657 subjects with calcifications, 718 cardiovascular deaths were observed. In two of the nine studies the imaging technique was US, one study employed CT, and in the remainder plain radiographs were used. The overall OR for cardiovascular mortality in the presence of calcifi cations was 3.94 (95% CI 2.39 to 6.50), but there was signifi cant heterogeneity among the studies (Figure 1 ).
Coronary events
Data on coronary events were available in 16 studies (17,482 events among 173,650 subjects). 3, 5, 6, 8, 15, 16, [22] [23] [24] 28, 29, 31, [33] [34] [35] 38 In the 19,261 subjects with calcifi cations, 1,534 events were observed resulting in an overall OR of 3.74 (95% CI 2.56 to 5.45; Figure 2) . Eight of these studies had utilized CT-scans of the coronaries and four used plain radiography. Thirteen studies originated from a North American population and most of the studies were done for screening purposes in an asymptomatic population. Average follow up in the CT-studies was only four years, but 18.7 years in the studies done with plain radiography.
Stroke
Stroke was reported as primary outcome in 11 studies with a total of 154,784 subjects of whom 9,889 showed calcifi cations. [5] [6] [7] [8] 18, [25] [26] [27] [28] 33, 39 In the group with calcifi cations there were 874 stroke cases. The total number of events was 10,454. Only one out of fi ve studies with ultrasound looked at calcifi cations of the carotid artery, whereas in the other four US of the heart valves was performed. The remaining six studies, all with plain radiographs, evaluated vascular calcifi cations of the breast, the thoracic or abdominal aorta and peripheral arteries. None of the studies with CT assessed the incidence of stroke. The overall OR for stroke was All cause mortality 
Any cardiovascular event
In 27 studies with a total of 192,205 patients and 34,958 events, the risk for any cardiovascular event could be studied ( Figure 3) . 3, [5] [6] [7] [8] [9] 12, 15, 16, 18, [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] 38, 39 In the 27,921 subjects with calcifi cations, 3,245 events were recorded. The average age was 59 years, but in the studies that reported the average age for the subjects with and without calcifi cations separately, age was signifi cantly higher in those with calcifi cations (63 versus 56 years, p Ͻ 0.05). The overall OR for any cardiovascular event with any modality was 3.41 (95% CI 2.71 to 4.30). This could be subdivided in an OR of 2.14 (95% CI 1.65 to 2.77) for ultrasound studies, 3.01 (95% CI 2.16 to 4.20) for plain radiographic studies, and 7.26 (95% CI 4.42 to 11.92) for studies using CT as diagnostic modality.
Meta regression analysis for any cardiovascular event
Meta-regression analysis with respect to the outcome of any cardiovascular event showed that the type of imaging technique and the duration of follow up were signifi cant causes of heterogeneity. After stratifying for imaging technique and follow up, the meta-analysis showed substantially lesser or no signifi cant heterogeneity. Figure 4 is shown as an example for the CT studies. However, the number of studies per group was also much smaller giving rise to less chance for heterogeneity. When data of high risk populations or populations with renal insuffi ciency or diabetes mellitus were analyzed separately there was also no signifi cant heterogeneity (chi-squared = 1.52 
Subgroup analysis
Most studies have been performed in asymptomatic populations participating in a screening program. In some, however, the indication for the test was the presence of one or more cardiovascular risk factors. for populations with intermediate risk 9, 13, 27, 29, 34, 38, 39 and 4.20 (95% CI 2.44 to 7.23) in high risk subjects ( Figure 5) . 24, 28, 30, 33, 36 There was no signifi cant heterogeneity in the latter group for the pooled estimate.
When only subjects with renal insuffi ciency were considered the risk for any cardiovascular event in the presence of calcifi cations was even higher (Figure 6) . 19, 28, 30, 33, 36 All patients were on hemodialysis except for the patients in one study who were on continuous ambulatory peritoneal dialysis. 33 In these fi ve studies, comprising a total of 1098 persons, 124 events were observed. Among the 599 patients with calcifi cations, 104 had suffered an event. Odds ratios for any cardiovascular event were 6.22 (95% CI 2.73 to 14.14). This pooled estimate was without signifi cant heterogeneity. Although the confi dence intervals overlap, it seemed that the presence of calcifi cations had the highest predictive power for a cardiovascular or a cerebrovascular event in subjects with renal insuffi ciency.
Although three studies reported data from diabetic patients, only two of these gave suffi cient information to calculate odds ratios for cardiovascular mortality (2.27, 95% CI 1.70 to 3.04).
9,27 Of 1,192 patients, 508 had calcifi cations on plain radiography of the femoral arteries of which 139 of a total of 236 events occurred in the patients with calcifi cations.
Funnel plot
A funnel plot of the standard error of log odds ratio was performed to assess a possible publication bias (Figure 7) . This is based on the fact that the precision in the estimation, of the underlying effect of fi nding calcifi cation on outcome, will increase as the sample size of component studies increases. Effect estimates from small studies will therefore scatter more widely at the right of the graph, with the spread narrowing among larger studies to the left of the graph. In the absence of bias, the plot would appear to be symmetrical. Although it appears to be rather symmetrical, there are no studies in the right lower quadrant suggesting publication bias of small studies without any or a positive effect of calcifi cation on cardiovascular events. However there was no bias using statistical tests for bias such as the Egger (weighted regression) method (p for bias 0.24) or the Begg (rank correlation) method.
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Discussion
The objective of this meta-analysis was to assess the risks associated with calcifi cation of the arterial wall or cardiac valves, as observed with different imaging methods in populations with different baseline risk. We showed that the presence of calcifi cation with any type of imaging technique in these populations harbors a 3-4 times increased risk for mortality and cardiovascular events.
The present meta-analysis has several limitations. Firstly, it was not possible to adjust for age in our analysis, since age was not provided in all studies. Although calcifi cation becomes more prevalent with age, we had to use unadjusted data to assess the general risk of calcifi cation as seen on any mode of investigation. However, in almost all individual studies calcifi cation was an independent risk factor. Adjustment for age did not change their outcome substantially. Secondly, the possibility of publication bias has to be considered. The asymmetry as seen in the funnel plot suggests that this could be the case for small studies with no signifi cant effect on any cardiovascular event with calcifi cation. However, statistical tests did not indicate signifi cant publication bias. Furthermore, there was signifi cant heterogeneity among the studies that could largely be explained by the different investigational tools on the one hand and different duration of follow up on the other. For example, patients who are being evaluated by CT for coronary symptoms, run a substantially higher risk with a shorter time horizon than those in whom calcifi cations are found accidentally. When we analyzed the risk for any cardiovascular event separately in relation to the type of imaging technique and time of follow-up (Ͻ5 years and Ͼ5 years), heterogeneity disappeared for the US and CT studies (Figure 4 ), but signifi cant heterogeneity remained present in studies using plain radiography with follow-up longer than fi ve years. This persistent heterogeneity can possibly be explained by differences in population characteristics and calcifi cation. In the studies with diabetic patients medial calcifi cation was present in most cases. Medial calcifi cation is associated with higher odds ratios for events than intimal calcifi cations in diabetic patients and might thus be an explanation for persistent heterogeneity in radiographic studies with a long follow-up period. 9 Also the range of follow up time in these populations was much greater (2-26 years in plain radiograph studies, 1.5-16 in US studies, and 2.7-6.9 in CT studies). With respect to selection mechanisms and baseline risk, subgroup analysis of a renal insuffi ciency population showed the highest risk. CT data predicted the events best with the highest odds ratio. Moreover, when calcium was seen with coronary CT, events occurred after a relatively short follow up period. Although coronary calcifi cations as detected by CT were associated with a greater risk of events than calcifi cation in other areas, the difference in study populations preclude meaningful conclusions about the superiority of CT relative to other imaging modalities. Moreover, compared with plain X-rays or ultrasound studies, noncontrasted CT scans and EBCT are likely to be more sensitive for detecting small amounts of calcifi cation. Interestingly, in hemodialysis patients were plain radiography or US were used to detect calcifi cations some of the highest odds ratios for all cause mortality and cardiovascular mortality were seen. 19, 28, 30, 33, 36 This might refl ect their lower sensitivity for detecting any calcifi cation. Half of the studies that reported on all cause mortality concerned a high-risk patient group with renal insuffi ciency. This infl uenced the odds ratio resulting in a relatively high risk for all cause mortality. Nevertheless, when we calculated the odds ratio for populations without renal insuffi ciency, this was still signifi cantly increased (3.43; 95% CI 1.26 to 9.32).
The results of this meta-analysis help to clarify the importance of calcifi cation in all sorts of patients. Although the reported odds ratios should be interpreted with caution because of substantial heterogeneity across studies, it showed that in almost any case of calcifi cation there is an increased cardiovascular risk. It is important to realize that subjects with vascular calcifi cation are high-risk patients. Currently, however, there is no specifi c therapy to reduce these calcifi cations and no evidence to support a better cardiovascular outcome with calcifi cation reduction, although data from animal research and from human cells in vivo on the actions of matrix Gla protein as an active calcifi cation inhibitor show promising results. [40] [41] [42] The use of statins reduces the cardiovascular event rate in almost all patient groups, but data on their calcifi cation inhibiting properties are confl icting. [43] [44] [45] [46] [47] [48] To our knowledge, there are no studies exploring the effect of treating all cardiovascular risk factors in patients based only on the presence of calcifi cations. However, extensive coronary calcifi cations justify further investigations for coronary plaques. Therefore, we feel that the practicing physician is also justifi ed to screen subjects, in whom calcifi cations are accidentally detected, for treatable risk factors. If these are present, the cardiovascular risk according to risk charts should be assessed. If the outcome exceeds the threshold defi ned in guidelines, the physician should take measures to reduce the cardiovascular risk of his or her patient.
